InsidersTradesSigma
Discover the full record of transactions filed by VANCE DOLLY, Directeur Exécutif. Director active across 1 company, notably RIGEL PHARMACEUTICALS INC. Aggregated, 2 filings have been logged. Activity tracked since 24 January 2022. The latest transaction was filed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
VANCE DOLLY is the Executive Vice President of Corporate Affairs, General Counsel, and Secretary at RIGEL PHARMACEUTICALS INC. She oversees the company's legal affairs and regulatory compliance. Her role is essential in ensuring that the organization adheres to laws while pursuing its business objectives.